We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

1npv

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1npv.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:1npv.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1npv| PDB=1npv | SCENE= }}
{{STRUCTURE_1npv| PDB=1npv | SCENE= }}
-
'''Crystal structure of HIV-1 protease complexed with LDC271'''
+
===Crystal structure of HIV-1 protease complexed with LDC271===
-
==Overview==
+
<!--
-
The design, synthesis, and biological evaluation of a series of HIV-1 protease inhibitors [(-)-6, (-)-7, (-)-23, (+)-24] based upon the 3,5,5-trisubstituted pyrrolin-4-one scaffold is described. Use of a monopyrrolinone scaffold leads to inhibitors with improved cellular transport properties relative to the earlier inhibitors based on bispyrrolinones and their peptide counterparts. The most potent inhibitor (-)-7 displayed 13% oral bioavailability in dogs. X-ray structure analysis of the monopyrrolinone compounds cocrystallized with the wild-type HIV-1 protease provided valuable information on the interactions between the inhibitors and the HIV-1 enzyme. In each case, the inhibitors assumed similar orientations for the P2'-P1 substituents, along with an unexpected hydrogen bond of the pyrrolinone NH with Asp225. Interactions with the S2 pocket, however, were not optimal, as illustrated by the inclusion of a water molecule in two of the three inhibitor-enzyme complexes. Efforts to increase affinity by displacing the water molecule with second and third generation inhibitors did not prove successful. Lack of success with this venture is a testament to the difficulty of accurately predicting the many variables that influence and build binding affinity. Comparison of the inhibitor positions in three complexes with that of Indinavir revealed displacements of the protease backbones in the enzyme flap region, accompanied by variations in hydrogen bonding to accommodate the monopyrrolinone ring. The binding orientation of the pyrrolinone-based inhibitors may explain their sustained efficacy against mutant strains of the HIV-1 protease enzyme as compared to Indinavir.
+
The line below this paragraph, {{ABSTRACT_PUBMED_12723947}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 12723947 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_12723947}}
==About this Structure==
==About this Structure==
Line 26: Line 30:
[[Category: Hydrolase]]
[[Category: Hydrolase]]
[[Category: Protease]]
[[Category: Protease]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 02:50:09 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 27 13:41:28 2008''

Revision as of 10:41, 27 July 2008

Image:1npv.png

Template:STRUCTURE 1npv

Crystal structure of HIV-1 protease complexed with LDC271

Template:ABSTRACT PUBMED 12723947

About this Structure

1NPV is a Single protein structure of sequence from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.

Reference

Design, synthesis, and biological evaluation of monopyrrolinone-based HIV-1 protease inhibitors., Smith AB 3rd, Cantin LD, Pasternak A, Guise-Zawacki L, Yao W, Charnley AK, Barbosa J, Sprengeler PA, Hirschmann R, Munshi S, Olsen DB, Schleif WA, Kuo LC, J Med Chem. 2003 May 8;46(10):1831-44. PMID:12723947

Page seeded by OCA on Sun Jul 27 13:41:28 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1npv"
Personal tools